speb/financial-data huggingface dataset:
CLOUD.OL income_statement (quarterly, 2026-03-31) — Operating Income: 40000000.00
CLOUD.OL income_statement (quarterly, 2026-03-31) — Operating Revenue: 191000000.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 336084938.00
CLOUD.OL cash_flow (quarterly, 2026-03-31) — Other Cash Adjustment Outside Changein Cash: 1000000.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 132000000.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 730000000.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 2000000.00
CLOUD.OL cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 26000000.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 91000000.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: -1000000.00
CLOUD.OL income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 3000000.00
CLOUD.OL income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 48000000.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Other Properties: 147000000.00
CLOUD.OL income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Payables: 35000000.00
CLOUD.OL income_statement (quarterly, 2026-03-31) — Pretax Income: 102000000.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Properties: 5409000000.00
CLOUD.OL cash_flow (quarterly, 2026-03-31) — Purchase Of Business: -19000000.00
CLOUD.OL cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -8000000.00
CLOUD.OL cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -50000000.00
CLOUD.OL income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 17000000.00
CLOUD.OL income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 55000000.00
CLOUD.OL cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -162000000.00
CLOUD.OL cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 0.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Share Issued: 336084938.00
CLOUD.OL cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: -29000000.00
CLOUD.OL income_statement (quarterly, 2026-03-31) — Special Income Charges: 0.00
CLOUD.OL cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 1000000.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 4864000000.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 4518000000.00
CLOUD.OL income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CLOUD.OL income_statement (quarterly, 2026-03-31) — Tax Provision: 3000000.00
CLOUD.OL income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.03
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Total Assets: 9804000000.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 6721000000.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Total Debt: 3641000000.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 5515000000.00
CLOUD.OL income_statement (quarterly, 2026-03-31) — Total Expenses: 151000000.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 4289000000.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 8689000000.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 2406000000.00
CLOUD.OL income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 123000000.00
CLOUD.OL income_statement (quarterly, 2026-03-31) — Total Other Finance Cost: -16000000.00
CLOUD.OL income_statement (quarterly, 2026-03-31) — Total Unusual Items: 0.00
CLOUD.OL income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 0.00
CLOUD.OL balance_sheet (quarterly, 2026-03-31) — Working Capital: -768000000.00
CLOV balance_sheet (annual, 2021-12-31) — Capital Lease Obligations: 7889000.00
CLOV balance_sheet (annual, 2021-12-31) — Current Capital Lease Obligation: 3059000.00
CLOV balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 3059000.00
CLOV balance_sheet (annual, 2021-12-31) — Current Deferred Liabilities: 138604000.00
CLOV balance_sheet (annual, 2021-12-31) — Current Deferred Revenue: 138604000.00
CLOV balance_sheet (annual, 2021-12-31) — Current Provisions: 110628000.00
CLOV balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 0.00
CLOV balance_sheet (annual, 2021-12-31) — Dueto Related Parties Current: 2320000.00
CLOV cash_flow (annual, 2021-12-31) — Gain Loss On Sale Of PPE: 0.00
CLOV cash_flow (annual, 2021-12-31) — Interest Paid Supplemental Data: 1677000.00
CLOV cash_flow (annual, 2021-12-31) — Issuance Of Debt: 0.00
CLOV balance_sheet (annual, 2021-12-31) — Long Term Capital Lease Obligation: 4830000.00
CLOV balance_sheet (annual, 2021-12-31) — Long Term Debt: 19938000.00
CLOV balance_sheet (annual, 2021-12-31) — Long Term Debt And Capital Lease Obligation: 24768000.00
CLOV cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 0.00
CLOV cash_flow (annual, 2021-12-31) — Long Term Debt Payments: -30925000.00
CLOV balance_sheet (annual, 2021-12-31) — Minority Interest: 3903000.00
CLOV cash_flow (annual, 2021-12-31) — Net Business Purchase And Sale: 0.00
CLOV cash_flow (annual, 2021-12-31) — Net Issuance Payments Of Debt: -30925000.00
CLOV cash_flow (annual, 2021-12-31) — Net Long Term Debt Issuance: -30925000.00
CLOV cash_flow (annual, 2021-12-31) — Net Other Financing Charges: 666241000.00
CLOV income_statement (annual, 2021-12-31) — Other Operating Expenses: 110819000.00
CLOV balance_sheet (annual, 2021-12-31) — Preferred Securities Outside Stock Equity: 0.00
CLOV cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 305000.00
CLOV cash_flow (annual, 2021-12-31) — Purchase Of Business: 0.00
CLOV cash_flow (annual, 2021-12-31) — Repayment Of Debt: -30925000.00
CLOV balance_sheet (annual, 2021-12-31) — Restricted Cash: 10656000.00
CLOV balance_sheet (annual, 2021-12-31) — Total Debt: 27827000.00
CLOV income_statement (annual, 2022-12-31) — +Operating Expense: 390143000.00
CLOV income_statement (annual, 2022-12-31) — +Total Revenue: 1096552000.00
CLOV balance_sheet (annual, 2022-12-31) — Accounts Payable: 32445000.00
CLOV balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -2311000.00
CLOV balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 2319157000.00
CLOV cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
CLOV balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 137368000.00
CLOV income_statement (annual, 2022-12-31) — Basic Average Shares: 476244262.00
CLOV income_statement (annual, 2022-12-31) — Basic EPS: -0.71
CLOV cash_flow (annual, 2022-12-31) — Beginning Cash Position: 299968000.00
CLOV cash_flow (annual, 2022-12-31) — Capital Expenditure: -4467000.00
CLOV balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 5860000.00
CLOV balance_sheet (annual, 2022-12-31) — Capital Stock: 46000.00
CLOV balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 103791000.00
CLOV balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 334761000.00
CLOV cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -4962000.00
CLOV cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: 95133000.00
CLOV cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -304600000.00
CLOV cash_flow (annual, 2022-12-31) — Cash From Discontinued Operating Activities: 100674000.00
CLOV cash_flow (annual, 2022-12-31) — Change In Account Payable: 7635000.00
CLOV cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 8784000.00
CLOV cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -8208000.00
CLOV cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -203000.00
CLOV cash_flow (annual, 2022-12-31) — Change In Other Working Capital: 1077000.00
CLOV cash_flow (annual, 2022-12-31) — Change In Payable: 7635000.00
CLOV cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 16419000.00
CLOV cash_flow (annual, 2022-12-31) — Change In Prepaid Assets: -3415000.00
CLOV cash_flow (annual, 2022-12-31) — Change In Receivables: -8029000.00
CLOV cash_flow (annual, 2022-12-31) — Change In Working Capital: -2359000.00
CLOV cash_flow (annual, 2022-12-31) — Changes In Cash: -113755000.00
CLOV balance_sheet (annual, 2022-12-31) — Common Stock: 46000.00
CLOV balance_sheet (annual, 2022-12-31) — Common Stock Equity: 356887000.00
CLOV cash_flow (annual, 2022-12-31) — Common Stock Issuance: 1400000.00
CLOV cash_flow (annual, 2022-12-31) — Common Stock Payments: -6362000.00
CLOV income_statement (annual, 2022-12-31) — Cost Of Revenue: 993073000.00
CLOV balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 23962000.00
CLOV balance_sheet (annual, 2022-12-31) — Current Assets: 624997000.00
CLOV balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 1827000.00
CLOV balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 1827000.00
CLOV balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 0.00
CLOV balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 0.00
CLOV balance_sheet (annual, 2022-12-31) — Current Liabilities: 431507000.00
CLOV balance_sheet (annual, 2022-12-31) — Current Provisions: 7239000.00
CLOV cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 1187000.00
CLOV income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 1187000.00
CLOV cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1187000.00
CLOV income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 1187000.00
CLOV income_statement (annual, 2022-12-31) — Diluted Average Shares: 476244262.00
CLOV income_statement (annual, 2022-12-31) — Diluted EPS: -0.71
CLOV income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -339567000.00
CLOV balance_sheet (annual, 2022-12-31) — Dueto Related Parties Current: 1566000.00
CLOV income_statement (annual, 2022-12-31) — EBIT: -253221000.00
CLOV income_statement (annual, 2022-12-31) — EBITDA: -252034000.00
CLOV cash_flow (annual, 2022-12-31) — End Cash Position: 186213000.00
CLOV cash_flow (annual, 2022-12-31) — Financing Cash Flow: -4962000.00
CLOV cash_flow (annual, 2022-12-31) — Free Cash Flow: -208393000.00
CLOV cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -9850000.00
CLOV income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 10117000.00
CLOV balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -9374000.00
CLOV income_statement (annual, 2022-12-31) — General And Administrative Expense: 482403000.00
CLOV balance_sheet (annual, 2022-12-31) — Goodwill: 11749000.00
CLOV balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 20000000.00
CLOV balance_sheet (annual, 2022-12-31) — Gross PPE: 12089000.00
CLOV income_statement (annual, 2022-12-31) — Gross Profit: 103479000.00
CLOV balance_sheet (annual, 2022-12-31) — Held To Maturity Securities: 742000.00
CLOV income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
CLOV income_statement (annual, 2022-12-31) — Interest Expense: 1363000.00
CLOV income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 1363000.00
CLOV cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 0.00
CLOV balance_sheet (annual, 2022-12-31) — Invested Capital: 356887000.00
CLOV cash_flow (annual, 2022-12-31) — Investing Cash Flow: 95133000.00
CLOV balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 138110000.00
CLOV balance_sheet (annual, 2022-12-31) — Investments And Advances: 138110000.00
CLOV cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 1400000.00
CLOV cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CLOV balance_sheet (annual, 2022-12-31) — Leases: 3035000.00
CLOV balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 4033000.00
CLOV balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 4033000.00
CLOV cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CLOV cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
CLOV balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 4741000.00
CLOV balance_sheet (annual, 2022-12-31) — Minority Interest: 0.00
CLOV cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -16200000.00
CLOV cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: -4962000.00
CLOV income_statement (annual, 2022-12-31) — Net Income: -339567000.00
CLOV income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -339567000.00
CLOV income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -254584000.00
CLOV income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: -84983000.00
CLOV income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -339567000.00
CLOV income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -254584000.00
CLOV cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -339567000.00
CLOV income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -339567000.00
CLOV income_statement (annual, 2022-12-31) — Net Interest Income: -1363000.00
CLOV cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 115800000.00
CLOV cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
CLOV cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
CLOV income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -1363000.00
CLOV cash_flow (annual, 2022-12-31) — Net Other Financing Charges: 82422000.00
CLOV balance_sheet (annual, 2022-12-31) — Net PPE: 9778000.00
CLOV cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -4467000.00
CLOV balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 336887000.00
CLOV income_statement (annual, 2022-12-31) — Normalized EBITDA: -285477000.00
CLOV income_statement (annual, 2022-12-31) — Normalized Income: -288027000.00
CLOV cash_flow (annual, 2022-12-31) — Operating Cash Flow: -203926000.00
CLOV cash_flow (annual, 2022-12-31) — Operating Gains Losses: -33176000.00
CLOV income_statement (annual, 2022-12-31) — Operating Income: -286664000.00
CLOV income_statement (annual, 2022-12-31) — Operating Revenue: 1084869000.00
CLOV balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 478393570.00
CLOV balance_sheet (annual, 2022-12-31) — Other Current Assets: 4043000.00
CLOV balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 74330000.00
CLOV balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -9374000.00
CLOV income_statement (annual, 2022-12-31) — Other Gand A: 203678000.00
CLOV income_statement (annual, 2022-12-31) — Other Income Expense: 33443000.00
CLOV balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 8251000.00
CLOV cash_flow (annual, 2022-12-31) — Other Non Cash Items: -1473000.00
CLOV balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 15735000.00
CLOV balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 16193000.00
CLOV income_statement (annual, 2022-12-31) — Other Operating Expenses: -93447000.00
CLOV balance_sheet (annual, 2022-12-31) — Other Payable: 290138000.00
CLOV balance_sheet (annual, 2022-12-31) — Other Properties: 4313000.00
CLOV balance_sheet (annual, 2022-12-31) — Other Receivables: 167545000.00
CLOV balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 230970000.00
CLOV income_statement (annual, 2022-12-31) — Other Special Charges: -23326000.00
CLOV balance_sheet (annual, 2022-12-31) — Payables: 324149000.00
CLOV balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 348111000.00
CLOV balance_sheet (annual, 2022-12-31) — Prepaid Assets: 18146000.00
CLOV income_statement (annual, 2022-12-31) — Pretax Income: -254584000.00
CLOV cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
CLOV balance_sheet (annual, 2022-12-31) — Properties: 0.00
CLOV cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: -93517000.00
CLOV cash_flow (annual, 2022-12-31) — Purchase Of Business: -16200000.00
CLOV cash_flow (annual, 2022-12-31) — Purchase Of Investment: -369646000.00
CLOV cash_flow (annual, 2022-12-31) — Purchase Of PPE: -4467000.00
CLOV balance_sheet (annual, 2022-12-31) — Receivables: 167545000.00
CLOV income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 993073000.00
CLOV income_statement (annual, 2022-12-31) — Reconciled Depreciation: 1187000.00
CLOV cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
CLOV cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: -6362000.00
CLOV balance_sheet (annual, 2022-12-31) — Restricted Cash: 100502000.00
CLOV income_statement (annual, 2022-12-31) — Restructuring And Mergern Acquisition: 0.00
CLOV balance_sheet (annual, 2022-12-31) — Retained Earnings: -1946433000.00
CLOV income_statement (annual, 2022-12-31) — Salaries And Wages: 278725000.00
CLOV cash_flow (annual, 2022-12-31) — Sale Of Investment: 485446000.00
CLOV income_statement (annual, 2022-12-31) — Selling General And Administration: 482403000.00
CLOV balance_sheet (annual, 2022-12-31) — Share Issued: 480466322.00
CLOV income_statement (annual, 2022-12-31) — Special Income Charges: 23326000.00
CLOV cash_flow (annual, 2022-12-31) — Stock Based Compensation: 164305000.00
CLOV balance_sheet (annual, 2022-12-31) — Stockholders Equity: 356887000.00
CLOV balance_sheet (annual, 2022-12-31) — Tangible Book Value: 336887000.00
CLOV income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CLOV income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
CLOV balance_sheet (annual, 2022-12-31) — Total Assets: 808620000.00
CLOV balance_sheet (annual, 2022-12-31) — Total Capitalization: 356887000.00
CLOV balance_sheet (annual, 2022-12-31) — Total Debt: 5860000.00
CLOV balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 356887000.00
CLOV income_statement (annual, 2022-12-31) — Total Expenses: 1383216000.00
CLOV balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 451733000.00
CLOV balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 183623000.00
CLOV balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 20226000.00
CLOV income_statement (annual, 2022-12-31) — Total Operating Income As Reported: -286664000.00
CLOV income_statement (annual, 2022-12-31) — Total Unusual Items: 33443000.00
CLOV income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 33443000.00
CLOV balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 2072752.00
CLOV balance_sheet (annual, 2022-12-31) — Treasury Stock: 6509000.00
CLOV balance_sheet (annual, 2022-12-31) — Working Capital: 193490000.00
CLOV income_statement (annual, 2023-12-31) — +Operating Expense: 435516000.00
CLOV income_statement (annual, 2023-12-31) — +Total Revenue: 1260543000.00
CLOV balance_sheet (annual, 2023-12-31) — Accounts Payable: 37184000.00
CLOV balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -4583000.00
CLOV balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 2461238000.00
CLOV cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 15945000.00
CLOV balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 72471000.00
CLOV balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 120208000.00
CLOV income_statement (annual, 2023-12-31) — Basic Average Shares: 482176127.00
CLOV income_statement (annual, 2023-12-31) — Basic EPS: -0.44
CLOV cash_flow (annual, 2023-12-31) — Beginning Cash Position: 186213000.00
CLOV cash_flow (annual, 2023-12-31) — Capital Expenditure: -584000.00
CLOV balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 4663000.00
CLOV balance_sheet (annual, 2023-12-31) — Capital Stock: 49000.00
CLOV balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 116407000.00
CLOV balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 236229000.00
CLOV cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -5070000.00
CLOV cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: 140013000.00
CLOV cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -35148000.00
CLOV cash_flow (annual, 2023-12-31) — Cash From Discontinued Operating Activities: -109514000.00
CLOV cash_flow (annual, 2023-12-31) — Change In Account Payable: 4739000.00
CLOV cash_flow (annual, 2023-12-31) — Change In Accrued Expense: -2901000.00
CLOV cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 8859000.00
CLOV cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 6404000.00
CLOV cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -294000.00
CLOV cash_flow (annual, 2023-12-31) — Change In Payable: 4739000.00
CLOV cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 1838000.00
CLOV cash_flow (annual, 2023-12-31) — Change In Prepaid Assets: 3728000.00
CLOV cash_flow (annual, 2023-12-31) — Change In Receivables: 4754000.00
CLOV cash_flow (annual, 2023-12-31) — Change In Working Capital: 25289000.00
CLOV cash_flow (annual, 2023-12-31) — Changes In Cash: -9719000.00
CLOV balance_sheet (annual, 2023-12-31) — Common Stock: 49000.00
CLOV balance_sheet (annual, 2023-12-31) — Common Stock Equity: 286394000.00
CLOV cash_flow (annual, 2023-12-31) — Common Stock Issuance: 1150000.00
CLOV cash_flow (annual, 2023-12-31) — Common Stock Payments: -6220000.00
CLOV income_statement (annual, 2023-12-31) — Cost Of Revenue: 1004590000.00
CLOV balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 20951000.00
CLOV balance_sheet (annual, 2023-12-31) — Current Assets: 427970000.00
CLOV balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 1665000.00
CLOV balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 1665000.00
CLOV balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 3099000.00
CLOV balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 3099000.00
CLOV balance_sheet (annual, 2023-12-31) — Current Liabilities: 261115000.00
CLOV cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 2509000.00
CLOV income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 2509000.00
CLOV cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 2509000.00
CLOV income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 2509000.00
CLOV income_statement (annual, 2023-12-31) — Diluted Average Shares: 482176127.00
CLOV income_statement (annual, 2023-12-31) — Diluted EPS: -0.44
CLOV income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -213361000.00
CLOV balance_sheet (annual, 2023-12-31) — Dueto Related Parties Current: 1363000.00
CLOV income_statement (annual, 2023-12-31) — EBIT: -210141000.00
CLOV income_statement (annual, 2023-12-31) — EBITDA: -207632000.00
CLOV cash_flow (annual, 2023-12-31) — End Cash Position: 176494000.00
CLOV cash_flow (annual, 2023-12-31) — Financing Cash Flow: -5070000.00
CLOV cash_flow (annual, 2023-12-31) — Free Cash Flow: -145246000.00
CLOV cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 4792000.00
CLOV income_statement (annual, 2023-12-31) — Gain On Sale Of Security: -4812000.00
CLOV balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -2370000.00
CLOV income_statement (annual, 2023-12-31) — General And Administrative Expense: 440246000.00
CLOV balance_sheet (annual, 2023-12-31) — Goodwill: 0.00
CLOV balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 2990000.00
CLOV balance_sheet (annual, 2023-12-31) — Gross PPE: 9665000.00
CLOV income_statement (annual, 2023-12-31) — Gross Profit: 255953000.00
CLOV balance_sheet (annual, 2023-12-31) — Held To Maturity Securities: 793000.00
CLOV income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 15945000.00
CLOV income_statement (annual, 2023-12-31) — Interest Expense: 7000.00
CLOV income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 7000.00
CLOV cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 0.00
CLOV balance_sheet (annual, 2023-12-31) — Invested Capital: 286394000.00
CLOV cash_flow (annual, 2023-12-31) — Investing Cash Flow: 140013000.00
CLOV balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 121001000.00
CLOV balance_sheet (annual, 2023-12-31) — Investments And Advances: 121001000.00
CLOV cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 1150000.00
CLOV balance_sheet (annual, 2023-12-31) — Leases: 3035000.00
CLOV balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 2998000.00
CLOV balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 2998000.00
CLOV cash_flow (annual, 2023-12-31) — Long Term Debt Payments: 0.00
CLOV balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 6517000.00
CLOV balance_sheet (annual, 2023-12-31) — Minority Interest: 0.00
CLOV cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
CLOV cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -5070000.00
CLOV income_statement (annual, 2023-12-31) — Net Income: -213361000.00
CLOV income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -213361000.00
CLOV income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -210148000.00
CLOV income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: -3213000.00
CLOV income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -213361000.00
CLOV income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -210148000.00
CLOV cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -213361000.00
CLOV income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -213361000.00
CLOV income_statement (annual, 2023-12-31) — Net Interest Income: -7000.00
CLOV cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 140597000.00
CLOV cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 0.00
CLOV cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 0.00
CLOV income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -7000.00
CLOV cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -28791000.00
CLOV balance_sheet (annual, 2023-12-31) — Net PPE: 5082000.00
CLOV cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -584000.00
CLOV balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 283404000.00
CLOV income_statement (annual, 2023-12-31) — Normalized EBITDA: -177054000.00
CLOV income_statement (annual, 2023-12-31) — Normalized Income: -179570000.00
CLOV cash_flow (annual, 2023-12-31) — Operating Cash Flow: -144662000.00
CLOV cash_flow (annual, 2023-12-31) — Operating Gains Losses: 4792000.00
CLOV income_statement (annual, 2023-12-31) — Operating Income: -179563000.00
CLOV income_statement (annual, 2023-12-31) — Operating Revenue: 1235769000.00
CLOV balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 489051614.00
CLOV balance_sheet (annual, 2023-12-31) — Other Current Assets: 18612000.00
CLOV balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 65880000.00
CLOV balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -2370000.00
CLOV income_statement (annual, 2023-12-31) — Other Gand A: 183089000.00
CLOV income_statement (annual, 2023-12-31) — Other Income Expense: -30578000.00
CLOV balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 2990000.00
CLOV cash_flow (annual, 2023-12-31) — Other Non Cash Items: -4014000.00
CLOV balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 13628000.00
CLOV balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 23162000.00
CLOV income_statement (annual, 2023-12-31) — Other Operating Expenses: -7239000.00
CLOV balance_sheet (annual, 2023-12-31) — Other Payable: 137100000.00
CLOV balance_sheet (annual, 2023-12-31) — Other Properties: 113000.00
CLOV balance_sheet (annual, 2023-12-31) — Other Receivables: 86240000.00
CLOV balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 119822000.00
CLOV balance_sheet (annual, 2023-12-31) — Payables: 174284000.00
CLOV balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 195235000.00
CLOV balance_sheet (annual, 2023-12-31) — Prepaid Assets: 14418000.00
CLOV income_statement (annual, 2023-12-31) — Pretax Income: -210148000.00
CLOV cash_flow (annual, 2023-12-31) — Proceeds From Stock Option Exercised: 0.00
CLOV balance_sheet (annual, 2023-12-31) — Properties: 0.00
CLOV cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: -7239000.00
CLOV cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
CLOV cash_flow (annual, 2023-12-31) — Purchase Of Investment: -175567000.00
CLOV cash_flow (annual, 2023-12-31) — Purchase Of PPE: -584000.00
CLOV balance_sheet (annual, 2023-12-31) — Receivables: 86240000.00
CLOV income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 1004590000.00
CLOV income_statement (annual, 2023-12-31) — Reconciled Depreciation: 2509000.00
CLOV cash_flow (annual, 2023-12-31) — Repayment Of Debt: 0.00
CLOV cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -6220000.00
CLOV balance_sheet (annual, 2023-12-31) — Restricted Cash: 55631000.00
CLOV income_statement (annual, 2023-12-31) — Restructuring And Mergern Acquisition: 9821000.00
CLOV balance_sheet (annual, 2023-12-31) — Retained Earnings: -2159794000.00
CLOV income_statement (annual, 2023-12-31) — Salaries And Wages: 257157000.00
CLOV cash_flow (annual, 2023-12-31) — Sale Of Investment: 316164000.00
CLOV income_statement (annual, 2023-12-31) — Selling General And Administration: 440246000.00
CLOV balance_sheet (annual, 2023-12-31) — Share Issued: 496964364.00
CLOV income_statement (annual, 2023-12-31) — Special Income Charges: -25766000.00
CLOV cash_flow (annual, 2023-12-31) — Stock Based Compensation: 140931000.00
CLOV balance_sheet (annual, 2023-12-31) — Stockholders Equity: 286394000.00
CLOV balance_sheet (annual, 2023-12-31) — Tangible Book Value: 283404000.00
CLOV income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CLOV income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
CLOV balance_sheet (annual, 2023-12-31) — Total Assets: 570671000.00
CLOV balance_sheet (annual, 2023-12-31) — Total Capitalization: 286394000.00
CLOV balance_sheet (annual, 2023-12-31) — Total Debt: 4663000.00
CLOV balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 286394000.00
CLOV income_statement (annual, 2023-12-31) — Total Expenses: 1440106000.00
CLOV balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 284277000.00
CLOV balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 142701000.00
CLOV balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 23162000.00
CLOV income_statement (annual, 2023-12-31) — Total Operating Income As Reported: -205329000.00
CLOV income_statement (annual, 2023-12-31) — Total Unusual Items: -30578000.00
CLOV income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -30578000.00
CLOV balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 7912750.00
CLOV balance_sheet (annual, 2023-12-31) — Treasury Stock: 12729000.00
CLOV balance_sheet (annual, 2023-12-31) — Working Capital: 166855000.00
CLOV balance_sheet (quarterly, 2024-09-30) — Assets Held For Sale Current: 10087000.00
CLOV balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 3666000.00
CLOV balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 1345000.00
CLOV balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 1345000.00
CLOV balance_sheet (quarterly, 2024-09-30) — Current Deferred Liabilities: 17000.00
CLOV balance_sheet (quarterly, 2024-09-30) — Current Deferred Revenue: 17000.00
CLOV balance_sheet (quarterly, 2024-09-30) — Dueto Related Parties Current: 1340000.00
CLOV income_statement (quarterly, 2024-09-30) — Interest Expense: 0.00
CLOV income_statement (quarterly, 2024-09-30) — Interest Expense Non Operating: 0.00
CLOV balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 2321000.00
CLOV balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 2321000.00
CLOV income_statement (quarterly, 2024-09-30) — Net Interest Income: 0.00
CLOV income_statement (quarterly, 2024-09-30) — Net Non Operating Interest Income Expense: 0.00
CLOV income_statement (quarterly, 2024-09-30) — Other Income Expense: 538000.00
CLOV cash_flow (quarterly, 2024-09-30) — Provisionand Write Offof Assets: 0.00
CLOV balance_sheet (quarterly, 2024-09-30) — Restricted Cash: 596000.00
CLOV balance_sheet (quarterly, 2024-09-30) — Total Debt: 3666000.00
CLOV income_statement (annual, 2024-12-31) — +Operating Expense: 410265000.00
CLOV income_statement (annual, 2024-12-31) — +Total Revenue: 1371131000.00
CLOV balance_sheet (annual, 2024-12-31) — Accounts Payable: 34564000.00
CLOV balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -5914000.00
CLOV balance_sheet (quarterly, 2024-12-31) — Accumulated Depreciation: -5914000.00
CLOV balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 2576471000.00
CLOV cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
CLOV balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 0.00
CLOV balance_sheet (quarterly, 2024-12-31) — Assets Held For Sale Current: 0.00
CLOV balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 201719000.00
CLOV income_statement (annual, 2024-12-31) — Basic Average Shares: 490018730.00
CLOV income_statement (annual, 2024-12-31) — Basic EPS: -0.08
CLOV cash_flow (annual, 2024-12-31) — Beginning Cash Position: 176494000.00
CLOV cash_flow (annual, 2024-12-31) — Capital Expenditure: -1556000.00
CLOV balance_sheet (annual, 2024-12-31) — Capital Stock: 50000.00
CLOV balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 194543000.00
CLOV balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 221555000.00
CLOV cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: -17361000.00
CLOV cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: 565000.00
CLOV cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 82450000.00
CLOV cash_flow (annual, 2024-12-31) — Cash From Discontinued Operating Activities: -47605000.00
CLOV cash_flow (quarterly, 2024-12-31) — Cash From Discontinued Operating Activities: -38744000.00
CLOV cash_flow (annual, 2024-12-31) — Change In Account Payable: -2620000.00
CLOV cash_flow (annual, 2024-12-31) — Change In Accrued Expense: -1971000.00
CLOV cash_flow (annual, 2024-12-31) — Change In Other Current Assets: 2852000.00
CLOV cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 606000.00
CLOV cash_flow (annual, 2024-12-31) — Change In Other Working Capital: 19296000.00
CLOV cash_flow (annual, 2024-12-31) — Change In Payable: -2620000.00
CLOV cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: -4591000.00
CLOV cash_flow (annual, 2024-12-31) — Change In Prepaid Assets: 1244000.00
CLOV cash_flow (annual, 2024-12-31) — Change In Receivables: -6552000.00
CLOV cash_flow (annual, 2024-12-31) — Change In Working Capital: 12855000.00
CLOV cash_flow (annual, 2024-12-31) — Changes In Cash: 18049000.00
CLOV balance_sheet (annual, 2024-12-31) — Common Stock: 50000.00
CLOV balance_sheet (annual, 2024-12-31) — Common Stock Equity: 341143000.00
CLOV cash_flow (annual, 2024-12-31) — Common Stock Issuance: 902000.00
CLOV cash_flow (annual, 2024-12-31) — Common Stock Payments: -18263000.00
CLOV income_statement (annual, 2024-12-31) — Cost Of Revenue: 1006327000.00
CLOV balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 19090000.00
CLOV balance_sheet (annual, 2024-12-31) — Current Assets: 343124000.00
CLOV balance_sheet (annual, 2024-12-31) — Current Liabilities: 213516000.00
CLOV cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1331000.00
CLOV income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 1331000.00
CLOV cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1331000.00
CLOV income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 1331000.00
CLOV income_statement (annual, 2024-12-31) — Diluted Average Shares: 490018730.00
CLOV income_statement (annual, 2024-12-31) — Diluted EPS: -0.08
CLOV income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -43009000.00
CLOV income_statement (annual, 2024-12-31) — EBIT: -46266000.00
CLOV income_statement (annual, 2024-12-31) — EBITDA: -44935000.00
CLOV cash_flow (annual, 2024-12-31) — End Cash Position: 194543000.00
CLOV cash_flow (annual, 2024-12-31) — Financing Cash Flow: -17361000.00
CLOV cash_flow (annual, 2024-12-31) — Free Cash Flow: 33289000.00
CLOV cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 37000.00
CLOV income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -517000.00
CLOV income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: -33000.00
CLOV balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -1584000.00
CLOV income_statement (annual, 2024-12-31) — General And Administrative Expense: 408934000.00
CLOV balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 2990000.00
CLOV balance_sheet (annual, 2024-12-31) — Gross PPE: 11221000.00
CLOV income_statement (annual, 2024-12-31) — Gross Profit: 364804000.00
CLOV balance_sheet (annual, 2024-12-31) — Held To Maturity Securities: 14343000.00
CLOV income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
CLOV income_statement (annual, 2024-12-31) — Interest Expense: 0.00
CLOV income_statement (quarterly, 2024-12-31) — Interest Expense: 0.00
CLOV income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 0.00
CLOV income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 0.00
CLOV balance_sheet (annual, 2024-12-31) — Invested Capital: 341143000.00
CLOV cash_flow (annual, 2024-12-31) — Investing Cash Flow: 565000.00
CLOV balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 216062000.00
CLOV balance_sheet (annual, 2024-12-31) — Investments And Advances: 216062000.00
CLOV cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 902000.00
CLOV balance_sheet (annual, 2024-12-31) — Leases: 3035000.00
CLOV balance_sheet (quarterly, 2024-12-31) — Leases: 3035000.00
CLOV balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 8073000.00
CLOV balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 8073000.00
CLOV cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
CLOV cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: -17361000.00
CLOV income_statement (annual, 2024-12-31) — Net Income: -43009000.00
CLOV income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -43009000.00
CLOV income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -46266000.00
CLOV income_statement (annual, 2024-12-31) — Net Income Discontinuous Operations: 3257000.00
CLOV income_statement (quarterly, 2024-12-31) — Net Income Discontinuous Operations: -611000.00
CLOV income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -43009000.00
CLOV income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -46266000.00
CLOV cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: -43009000.00
CLOV income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: -43009000.00
CLOV income_statement (annual, 2024-12-31) — Net Interest Income: 0.00
CLOV income_statement (quarterly, 2024-12-31) — Net Interest Income: 0.00
CLOV cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 2121000.00
CLOV income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: 0.00
CLOV income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: 0.00
CLOV balance_sheet (annual, 2024-12-31) — Net PPE: 5307000.00
CLOV cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: -1556000.00
CLOV balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 338153000.00
CLOV income_statement (annual, 2024-12-31) — Normalized EBITDA: -44130000.00
CLOV income_statement (annual, 2024-12-31) — Normalized Income: -45461000.00
CLOV cash_flow (annual, 2024-12-31) — Operating Cash Flow: 34845000.00
CLOV cash_flow (annual, 2024-12-31) — Operating Gains Losses: 37000.00
CLOV income_statement (annual, 2024-12-31) — Operating Income: -45461000.00
CLOV income_statement (annual, 2024-12-31) — Operating Revenue: 1344881000.00
CLOV balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 503525356.00
CLOV balance_sheet (annual, 2024-12-31) — Other Current Assets: 15603000.00
CLOV balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 3466000.00
CLOV balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -1584000.00
CLOV income_statement (annual, 2024-12-31) — Other Gand A: 176480000.00
CLOV income_statement (annual, 2024-12-31) — Other Income Expense: -805000.00
CLOV income_statement (quarterly, 2024-12-31) — Other Income Expense: -33000.00
CLOV balance_sheet (annual, 2024-12-31) — Other Intangible Assets: 2990000.00
CLOV balance_sheet (quarterly, 2024-12-31) — Other Intangible Assets: 2990000.00
CLOV cash_flow (annual, 2024-12-31) — Other Non Cash Items: -3095000.00
CLOV balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 13259000.00
CLOV balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 26083000.00
CLOV balance_sheet (annual, 2024-12-31) — Other Payable: 156396000.00
CLOV balance_sheet (annual, 2024-12-31) — Other Properties: 113000.00
CLOV balance_sheet (annual, 2024-12-31) — Other Receivables: 92792000.00
CLOV balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 27012000.00
CLOV balance_sheet (annual, 2024-12-31) — Payables: 190960000.00
CLOV balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 210050000.00
CLOV balance_sheet (annual, 2024-12-31) — Prepaid Assets: 13174000.00
CLOV income_statement (annual, 2024-12-31) — Pretax Income: -46266000.00
CLOV balance_sheet (annual, 2024-12-31) — Properties: 0.00
CLOV balance_sheet (quarterly, 2024-12-31) — Properties: 0.00
CLOV cash_flow (annual, 2024-12-31) — Provisionand Write Offof Assets: 0.00
CLOV cash_flow (quarterly, 2024-12-31) — Provisionand Write Offof Assets: 0.00
CLOV cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
CLOV cash_flow (annual, 2024-12-31) — Purchase Of Investment: -201241000.00
CLOV cash_flow (annual, 2024-12-31) — Purchase Of PPE: -1556000.00
CLOV balance_sheet (annual, 2024-12-31) — Receivables: 92792000.00
CLOV income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 1006327000.00
CLOV income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1331000.00
CLOV cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: -18263000.00
CLOV income_statement (annual, 2024-12-31) — Restructuring And Mergern Acquisition: 288000.00
CLOV income_statement (quarterly, 2024-12-31) — Restructuring And Mergern Acquisition: 0.00
CLOV balance_sheet (annual, 2024-12-31) — Retained Earnings: -2202803000.00
CLOV income_statement (annual, 2024-12-31) — Salaries And Wages: 232454000.00
CLOV cash_flow (annual, 2024-12-31) — Sale Of Investment: 203362000.00
CLOV income_statement (annual, 2024-12-31) — Selling General And Administration: 408934000.00
CLOV balance_sheet (annual, 2024-12-31) — Share Issued: 522278303.00
CLOV income_statement (annual, 2024-12-31) — Special Income Charges: -288000.00
CLOV income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
CLOV cash_flow (annual, 2024-12-31) — Stock Based Compensation: 114331000.00
CLOV balance_sheet (annual, 2024-12-31) — Stockholders Equity: 341143000.00
CLOV balance_sheet (annual, 2024-12-31) — Tangible Book Value: 338153000.00
CLOV income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
CLOV income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.00
CLOV balance_sheet (annual, 2024-12-31) — Total Assets: 580742000.00
CLOV balance_sheet (annual, 2024-12-31) — Total Capitalization: 341143000.00
CLOV balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 341143000.00
CLOV income_statement (annual, 2024-12-31) — Total Expenses: 1416592000.00
CLOV balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 239599000.00
CLOV balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 237618000.00
CLOV balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 26083000.00
CLOV income_statement (annual, 2024-12-31) — Total Operating Income As Reported: -45749000.00
CLOV income_statement (annual, 2024-12-31) — Total Unusual Items: -805000.00
CLOV income_statement (quarterly, 2024-12-31) — Total Unusual Items: -33000.00
CLOV income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -805000.00
CLOV income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: -33000.00
CLOV balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 18752947.00
CLOV balance_sheet (annual, 2024-12-31) — Treasury Stock: 30991000.00
CLOV balance_sheet (annual, 2024-12-31) — Working Capital: 129608000.00
CLOV income_statement (quarterly, 2025-03-31) — +Operating Expense: 110163000.00
CLOV income_statement (quarterly, 2025-03-31) — +Total Revenue: 462331000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 30553000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 2603123000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 216506000.00
CLOV income_statement (quarterly, 2025-03-31) — Basic Average Shares: 497056331.00
CLOV income_statement (quarterly, 2025-03-31) — Basic EPS: 0.00
CLOV cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 194543000.00
CLOV cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -185000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Capital Stock: 50000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 155439000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 160095000.00
CLOV cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -31741000.00
CLOV cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: 8930000.00
CLOV cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: -16293000.00
CLOV cash_flow (quarterly, 2025-03-31) — Cash From Discontinued Operating Activities: 0.00
CLOV cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -4011000.00
CLOV cash_flow (quarterly, 2025-03-31) — Change In Accrued Expense: 11433000.00
CLOV cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: -1147000.00
CLOV cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 5979000.00
CLOV cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -5358000.00
CLOV cash_flow (quarterly, 2025-03-31) — Change In Payable: -4011000.00
CLOV cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: 7422000.00
CLOV cash_flow (quarterly, 2025-03-31) — Change In Prepaid Assets: -3415000.00
CLOV cash_flow (quarterly, 2025-03-31) — Change In Receivables: -45464000.00
CLOV cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -41983000.00
CLOV cash_flow (quarterly, 2025-03-31) — Changes In Cash: -39104000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Common Stock: 50000.00
CLOV balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 336075000.00
CLOV cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 215000.00
CLOV cash_flow (quarterly, 2025-03-31) — Common Stock Payments: -31956000.00
CLOV income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 353442000.00